Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 2,500
- Avg volume
- —
- Day's range
- $1.93 – $2.00
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Cabbacis Inc., a development stage company, focuses on developing and commercializing modified risk tobacco products. The company is developing cigarettes and vaporizer pods for oral electronic vaporizers under the iBlend brand name. It operates in the United States, Canada, Mexico, Brazil, Europe, the United Kingdom, Switzerland, China, Russia, India, Japan, South Korea, Indonesia, Philippines, Australia, New Zealan...
Show more
Cabbacis Inc., a development stage company, focuses on developing and commercializing modified risk tobacco products. The company is developing cigarettes and vaporizer pods for oral electronic vaporizers under the iBlend brand name. It operates in the United States, Canada, Mexico, Brazil, Europe, the United Kingdom, Switzerland, China, Russia, India, Japan, South Korea, Indonesia, Philippines, Australia, New Zealand, and other countries. Cabbacis Inc. was incorporated in 2023 and is based in Niagara Falls, New York.
- Industry
- Tobacco
- Sector
- Consumer Defensive
- Phone
- 716 320 5525
- Website
- https://www.cabbacis.com
- Address
- 3193 Buffalo Avenue, Unit 1, Niagara Falls, United States
Latest news
No headlines yet.
